Search filters

List of works by Frédéric R Santer

Androgen receptor co-activators in the regulation of cellular events in prostate cancer.

scientific article

Androgen receptor signaling in prostate cancer.

scientific article published on September 2014

DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer

scientific article

Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways

scientific article

Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation.

scientific article published on 7 September 2007

Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines

scientific article published on 27 June 2011

Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics.

scientific article published on 13 December 2017

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

scientific article published on March 2015

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models

scientific article published on 02 August 2018

Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis.

scientific article published on March 2006

Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells.

scientific article published on 21 February 2018

SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.

scientific article published on 18 May 2010

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways ⬇️

scientific article published on May 3, 2012

Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases

scientific article

The STAT3 inhibitor galiellalactone reduces IL6-mediated AR activity in benign and malignant prostate models

scientific article published on 25 September 2018

Therapy escape mechanisms in the malignant prostate

scientific article

Transcriptional coactivators p300 and CBP stimulate estrogen receptor‐beta signaling and regulate cellular events in prostate cancer ⬇️

scientific article published on September 21, 2010

Paulina is supported by:

About Paulina

Help